Institut De Cancérologie De Lorraine
Clinical trials sponsored by Institut De Cancérologie De Lorraine, explained in plain language.
-
New microscope could spot cancer cells Mid-Surgery
Diagnosis OngoingThis study tests a special microscope that lets doctors check for leftover cancer cells right during surgery. It involves 42 adults with skin or head-and-neck cancers. The goal is to see if this quick method matches standard lab tests.
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated May 13, 2026 16:04 UTC
-
New program aims to stop chemo brain before it starts
Symptom relief OngoingThis study is testing whether a personalized support program led by a nurse can help prevent memory and thinking problems (often called 'chemo brain') in women with non-metastatic breast cancer who are about to start chemotherapy. Fifty women will receive 9 months of follow-up wi…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated May 11, 2026 20:39 UTC
-
Blood test could predict melanoma treatment failure
Knowledge-focused OngoingThis study looks at whether a personalized blood test that tracks tumor DNA can help doctors see if melanoma treatment is starting to fail. About 136 adults with stage IIB to IV melanoma will give blood samples while on standard therapy. The goal is to see if changes in the DNA l…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated May 17, 2026 00:26 UTC
-
Blood test may predict ovarian cancer relapse without surgery
Knowledge-focused OngoingThis study tests whether a blood test (liquid biopsy) can be used instead of multiple tissue samples to see how ovarian cancer changes over time. Twenty newly diagnosed patients will give blood and tissue samples during their treatment for up to 2 years. The goal is to see if the…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC